{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:40:37Z","timestamp":1768009237416,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission","doi-asserted-by":"publisher","award":["21-57\/SRGP\/R&D\/HEC\/2014"],"award-info":[{"award-number":["21-57\/SRGP\/R&D\/HEC\/2014"]}],"id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004681","name":"Higher Education Commission","doi-asserted-by":"publisher","award":["NRPU No: 20-4175\/NRPU\/R&D\/HEC\/14-595"],"award-info":[{"award-number":["NRPU No: 20-4175\/NRPU\/R&D\/HEC\/14-595"]}],"id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cbi.2017.06.015","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T07:31:06Z","timestamp":1497598266000},"page":"237-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats"],"prefix":"10.1016","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1219-2970","authenticated-orcid":false,"given":"Humera","family":"Jahan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Iqbal","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehwish","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid Mohammad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahnaz","family":"Perveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Atta-ur-Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2017.06.015_bib1","series-title":"Diabetes Atlas","author":"International Diabetes Federation","year":"2015"},{"key":"10.1016\/j.cbi.2017.06.015_bib2","first-page":"1","article-title":"Effect of Alpinia calcarata on glucose uptake in diabetic rats-an in\u00a0vitro and in\u00a0vivo model","volume":"33","author":"Rajasekar","year":"2014","journal-title":"J.\u00a0Diabetes Metab. Disord."},{"key":"10.1016\/j.cbi.2017.06.015_bib3","series-title":"Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks","year":"2009"},{"key":"10.1016\/j.cbi.2017.06.015_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1464-5491.2000.00309.x","article-title":"Socio-economic status, obesity and prevalence of type 1 and type 2 diabetes mellitus","volume":"17","author":"Evans","year":"2000","journal-title":"Diabet. Med. J. Br. Diabet. Assoc."},{"key":"10.1016\/j.cbi.2017.06.015_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/oxfordjournals.aje.a009728","article-title":"Estimating prevalence of type 1 and type 2 diabetes in a population of African Americans with diabetes mellitus","volume":"149","author":"Boyle","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cbi.2017.06.015_bib6","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2337\/diacare.28.11.2613","article-title":"Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: the population-based registry in the province of Turin, Italy","volume":"28","author":"Bruno","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2017.06.015_bib7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/dme.12791","article-title":"Current prevalence of type 1 and type 2 diabetes in adults and children in the UK","volume":"32","author":"Holman","year":"2015","journal-title":"Diabet. Med. J. Br. Diabet. Assoc."},{"key":"10.1016\/j.cbi.2017.06.015_bib8","series-title":"International Encyclopedia of Rehabilitation","article-title":"Type 2 diabetes mellitus and disability","author":"Bruce","year":"2010"},{"key":"10.1016\/j.cbi.2017.06.015_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.metabol.2008.10.012","article-title":"Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice","volume":"58","author":"Matsuyama -Yokono","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2017.06.015_bib10","series-title":"Food and Agriculture Organization UN. Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO\/FAO Expert Consultation","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.cbi.2017.06.015_bib11","first-page":"15","article-title":"The growing pandemic of type 2 diabetes: a crucial need for prevention and improved detection","volume":"33","author":"Zimmet","year":"2011","journal-title":"Medicographia"},{"key":"10.1016\/j.cbi.2017.06.015_bib12","first-page":"1267","article-title":"Glycation, carbonyl stress and AGEs inhibitors: a patent review","volume":"25","author":"Jahan","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.cbi.2017.06.015_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1172\/JCI10761","article-title":"Interactions between insulin resistance and insulin secretion in the development of glucose intolerance","volume":"106","author":"Cavaghan","year":"2000","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.cbi.2017.06.015_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2017.06.015_bib15","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI29103","article-title":"Islet b cell failure in type 2 diabetes","volume":"116","author":"Prentki","year":"2006","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.cbi.2017.06.015_bib16","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1210\/jc.2010-0449","article-title":"Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction","volume":"95","author":"Zeller","year":"2010","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2017.06.015_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2337\/diacare.15.6.737","article-title":"Sulfonylureas in NIDDM","volume":"15","author":"Groop","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2017.06.015_bib18","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.metabol.2006.02.006","article-title":"Long-term efficacy of sulfonylureas: a United Kingdom Prospective diabetes study perspective","volume":"55","author":"Holman","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2017.06.015_bib19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2017.06.015_bib20","first-page":"31","article-title":"Secondary failure of oral hypoglycemic agents: frequency, possible causes, and management","volume":"10","author":"Pontiroli","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2017.06.015_bib21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2337\/diab.46.5.808","article-title":"Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic rats","volume":"46","author":"Hosokawa","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2017.06.015_bib22","first-page":"298","article-title":"Impaired \u03b2-cell function with chronic hyperglycemia: \u2018overworked \u03b2-cell\u2019 hypothesis","volume":"4","author":"Leahy","year":"1996","journal-title":"Diabetes Rev."},{"key":"10.1016\/j.cbi.2017.06.015_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1464-5491.2001.00534.x","article-title":"Beta-cell function evaluated by HOMA as a predictor of secondary sulfonylureas failure in type 2 diabetes","volume":"18","author":"Taverna","year":"2001","journal-title":"Diabet. Med."},{"key":"10.1016\/j.cbi.2017.06.015_bib24","article-title":"Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity","volume":"48","author":"Kawaki","year":"2001","journal-title":"Diabetes1999"},{"key":"10.1016\/j.cbi.2017.06.015_bib25","first-page":"1747","article-title":"Oral agents in the management of type 2 diabetes mellitus","volume":"63","author":"Luna","year":"2001","journal-title":"Am. Fam. Physian"},{"key":"10.1016\/j.cbi.2017.06.015_bib26","first-page":"1219","article-title":"Synthesis, biological activity evaluation and QSAR studies of novel 3-(aminooxalyl-amino)-and 3-(carbamoyl-propionylamino)-2-phenylamino-benzoic acid derivatives","volume":"6","author":"Suleiman","year":"2014","journal-title":"J.\u00a0Chem. Pharm. Res."},{"key":"10.1016\/j.cbi.2017.06.015_bib27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/np050549h","article-title":"An antimalarial tetrapeptide from the entomopathogenic fungus Hirsustella sp. BCC 1528","volume":"69","author":"Thongtan","year":"2006","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.cbi.2017.06.015_bib28","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1021\/jm051050n","article-title":"Anthranilic acid based CCK1 receptor antagonists and CCK-8 have a common step in their \u201creceptor desmodynamic processes","volume":"49","author":"DeLuca","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.cbi.2017.06.015_bib29","first-page":"265","article-title":"Synthesis and pharmacological screening of N- substituted anthranilic acid derivatives","volume":"3","author":"Tiwari","year":"2011","journal-title":"Int J Drug Dev Res"},{"key":"10.1016\/j.cbi.2017.06.015_bib30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1476-5381.1990.tb14162.x","article-title":"Receptors involved in mechanical responses to catecholamines in the circular muscle of Guinea-pig stomach treated with meclofenamate","volume":"101","author":"Syed","year":"1990","journal-title":"Brit J. Pharm."},{"key":"10.1016\/j.cbi.2017.06.015_bib31","series-title":"The Extra Pharmacopoeia","first-page":"435","author":"Martindale","year":"1996"},{"key":"10.1016\/j.cbi.2017.06.015_bib32","series-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"1536","author":"Insel","year":"1990"},{"key":"10.1016\/j.cbi.2017.06.015_bib33","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.3390\/molecules16053544","article-title":"Microwave-assisted one-step synthesis of fenamic acid hydrazides from the corresponding acids","volume":"16","author":"Aboul-Fadl","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2017.06.015_bib34","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.bmcl.2004.09.045","article-title":"Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents","volume":"14","author":"Cocco","year":"2004","journal-title":"Bioorg Med. Chem. Let."},{"key":"10.1016\/j.cbi.2017.06.015_bib35","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.bmcl.2011.01.010","article-title":"Discovery of substituted 3-(phenylamino) benzoic acids as potent and selective inhibitors of type 5 17\u03b2-hydroxysteroid dehydrogenase (AKR1C3)","volume":"21","author":"Adeniji","year":"2011","journal-title":"Bioorg Med. Chem. Let."},{"key":"10.1016\/j.cbi.2017.06.015_bib36","unstructured":"Choudhary MI, Jahan H, Khan KM, Atta A, and Atta-ur-Rahman. Anthranilic acid derivatives: novel inhibitors of advanced glycation end products (AGES) formation. US Patent 2016; US9381182B2."},{"key":"10.1016\/j.cbi.2017.06.015_bib37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12011-010-8703-4","article-title":"Deterioration of bone quality by streptozotocin (STZ)-induced type 2 diabetes mellitus in rats","volume":"140","author":"Erdal","year":"2011","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.cbi.2017.06.015_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/FBP.0b013e3283512c00","article-title":"Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats","volume":"23","author":"Attia","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.cbi.2017.06.015_bib39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1056-8727(00)00079-9","article-title":"Prevention of endothelial dysfunction in streptozotocin-induced diabetic rats by gliclazide treatment","volume":"14","author":"Vallejo","year":"2000","journal-title":"J.\u00a0Diabetes Complicat."},{"key":"10.1016\/j.cbi.2017.06.015_bib40","first-page":"1","article-title":"Targeting AGEs signaling ameliorates central nervous system diabetic complications in rats","volume":"2015","author":"Zakaria","year":"2015","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2017.06.015_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14786411003766904","article-title":"Modulation of pancreatic \u00df-cell in neonatally streptozotocin- induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp","volume":"25","author":"Hafizur","year":"2011","journal-title":"Nat Prod. Res."},{"key":"10.1016\/j.cbi.2017.06.015_bib42","first-page":"1","article-title":"Drug-induced hepatotoxicity","author":"Mehta","year":"2014","journal-title":"Medscape Drugs & Dis."},{"key":"10.1016\/j.cbi.2017.06.015_bib43","unstructured":"Khalifah RG, Marti RE. Inhibitors of Advanced Glycation End Products, US Patent 2014; US20140187506 A1."},{"key":"10.1016\/j.cbi.2017.06.015_bib44","first-page":"872","article-title":"Pancreatic \u00df cell dedifferentiation in diabetes and redifferentiation following insulin therapy","volume":"19","author":"Wang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2017.06.015_bib45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","article-title":"The mechanisms of alloxan- and streptozotocin induced diabetes","volume":"51","author":"Lenzen","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2017.06.015_bib46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1254\/jphs.09178FP","article-title":"Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats","volume":"111","author":"Kwon","year":"2009","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2017.06.015_bib47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yjmcc.2009.03.018","article-title":"Metallothionein alleviates oxidative stress-induced endoplasmic reticulum stress and myocardial dysfunction","volume":"47","author":"Guo","year":"2009","journal-title":"J.\u00a0Mol. Cell Cardiol."},{"key":"10.1016\/j.cbi.2017.06.015_bib48","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.toxrep.2014.10.022","article-title":"Antioxidant effect of pomegranate against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats","volume":"1","author":"Aboonabia","year":"2014","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.cbi.2017.06.015_bib49","first-page":"1","article-title":"Fighting Progression of type 2 diabetes: beta cell is key","author":"Kahn","year":"2016","journal-title":"Medscape Diabetes & Endocrinol."},{"key":"10.1016\/j.cbi.2017.06.015_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2337\/diab.35.1.6","article-title":"Effects of tolbutamide pretreatment on the rate of conversion of newly synthesized proinsulin to insulin and the ompartmental characteristics of insulin storage in isolated rat islets","volume":"35","author":"Gold","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2017.06.015_bib51","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.metabol.2006.02.003","article-title":"The place of sulfonylureas in the therapy for type 2 diabetes mellitus","volume":"55","author":"Del Prato","year":"2006","journal-title":"Metabolism"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717302193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717302193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:46:22Z","timestamp":1757857582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279717302193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":51,"alternative-id":["S0009279717302193"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2017.06.015","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2017.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}